Time to decide about risk-reducing mastectomy: A case series of BRCA1/2 gene mutation carriers

被引:12
作者
McCullum M. [1 ]
Bottorff J.L. [2 ,3 ]
Kelly M. [2 ]
Kieffer S.A. [2 ,4 ]
Balneaves L.G. [2 ]
机构
[1] Hereditary Cancer Program, BC Cancer Agency, Vancouver, BC
[2] School of Nursing, University of British Columbia, Vancouver, BC
[3] Faculty of Health and Social Development, University of British Columbia - Okanagan, Kelowna, BC
[4] Department of Medical Genetics, University of British Columbia, Vancouver, BC
关键词
Breast Cancer; Breast Cancer Risk; Breast Reconstruction; Breast Cancer Screening; Decision Conflict;
D O I
10.1186/1472-6874-7-3
中图分类号
学科分类号
摘要
Background: The purpose of this research was to explore women's decision-making experiences related to the option of risk-reducing mastectomy (RM), using a case series of three women who are carriers of a BRCA1/2 gene mutation. Methods: Data was collected in a pilot study that assessed the response of women to an information booklet about RM and decision-making support strategies. A detailed analysis of three women's descriptions of their decision-making processes and outcomes was conducted. Results: All three women were carriers of a BRCA1/2 gene mutation and, although undecided, were leaning towards RM when initially assessed. Each woman reported a different RM decision outcome at last follow-up. Case #1 decided not to have RM, stating that RM was "too radical" and early detection methods were an effective strategy for dealing with breast cancer risk. Case #2 remained undecided about RM and, over time, she became less prepared to make a decision because she felt she did not have sufficient information about surgical effects. Case #3 had undergone RM by the time of her second follow-up interview and reported that she felt "a load off (her) mind now". Conclusion: RM decision making may shift over time and require decision support over an extended period. © 2007 McCullum et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 24 条
  • [1] Ford D., Easton D.F., Stratton M., Narod S., Goldgar D., Devilee P., Bishop D.T., Weber B., Lenoir G., Chang-Claude J., Sobol H., Teare M.D., Struewing J., Arason A., Scherneck S., Peto J., Rebbeck T.R., Tonin P., Neuhausen S., Barkardottir R., Eyfjord J., Lynch H., Ponder B.A., Gayther S.A., Zelada-Hedman M., Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families, Am J Hum Genet, 62, pp. 676-689, (1998)
  • [2] Meiser B., Butow P., Price M., Bennett B., Berry G., Tucker K., Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer, Journal of Women's Health, 12, pp. 769-777, (2003)
  • [3] Meiser B., Butow P., Friedlander M., Schnieden V., Gattas M., Kirk J., Suthers G., Haan E., Tucker K., Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer, Journal of Clinical Oncology, 18, pp. 2250-2257, (2000)
  • [4] van Dijk S., Otten W., Zoeteweij M.W., Timmermans D.R.M., van Asperen C.J., Breuning M.H., Tollenaar R., Kievit J., Genetic counselling and the intention to undergo prophylactic mastectomy: Effects of a breast cancer risk assessment, British Journal of Cancer, 88, pp. 1675-1681, (2003)
  • [5] Stefanek M., Hartmann L., Nelson W., Risk-reduction mastectomy: Clinical issues and research needs, Journal of the National Cancer Institute, 93, pp. 1297-1306, (2001)
  • [6] van Oostrom I., Meijers-Heijboer H., Lodder L.N., Duivenvoorden H.J., van Gool A.R., Seynaeve C., van der Meer C.A., Klijn J.G.M., van Geel B.N., Burger C.W., Wladimiroff J.W., Tibben A., Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: A 5-year follow-up study, Journal of Clinical Oncology, 21, pp. 3867-3874, (2003)
  • [7] Hatcher M.B., Fallowfield L.J., A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy, The Breast, 12, pp. 1-9, (2003)
  • [8] Zion S., Slezak J., Sellers T., Woods J., Arnold P.G., Petty P., Donohue J., Frost M., Schaid D., Hartmann L., Reoperations after prophylactic mastectomy with or without implant reconstruction, Cancer, 98, pp. 2152-2160, (2003)
  • [9] Bresser P.J.C., Seynaeve C., van Gool A.R., Brekelmans C.T., Meijers-Heijboer H., van Geel A.N., Menke-Pluijmers M.B., Duivenvoorden H.J., Klijn J.G.M., Tibben A., Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women, Plastic and Reconstructive Surgery, 117, pp. 1675-1682, (2006)
  • [10] Metcalfe K.A., Semple J.L., Narod S.A., Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: A descriptive study, Plastic and Reconstructive Surgery, 114, pp. 360-366, (2004)